Atossa Therapeutics (ATOS) P/E (2012 - 2026)
Atossa Therapeutics (ATOS) P/E from Nov 8, 2012 to Jul 21, 2026. The TTM Atossa Therapeutics (ATOS) P/E is -0.55. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Atossa Therapeutics (ATOS)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.55 | -74.95% |
| 2025 | -2.19 | -53.11% |
| 2024 | -4.68 | +25.44% |
| 2023 | -3.73 | +35.30% |
| 2022 | -2.76 | -71.70% |
| 2021 | -9.74 | +153.03% |
| 2020 | -3.85 | -61.46% |
| 2019 | -9.98 | +388.61% |
| 2018 | -2.04 | -54.44% |
| 2017 | -4.49 | -23.07% |
| 2016 | -5.83 | -25.96% |
| 2015 | -7.88 | -78.05% |
| 2014 | -35.87 | -32.88% |
| 2013 | -53.45 | -91.41% |
| 2012 | -621.98 | N/A |
Comparison Atossa Therapeutics (ATOS) P/E with competitors
Atossa Therapeutics (ATOS) P/E is -0.55.